CN104256065B - Eriocheir sinensis raising Chinese medicine composition and using method - Google Patents
Eriocheir sinensis raising Chinese medicine composition and using method Download PDFInfo
- Publication number
- CN104256065B CN104256065B CN201410454963.9A CN201410454963A CN104256065B CN 104256065 B CN104256065 B CN 104256065B CN 201410454963 A CN201410454963 A CN 201410454963A CN 104256065 B CN104256065 B CN 104256065B
- Authority
- CN
- China
- Prior art keywords
- group
- eriocheir sinensis
- chinese medicine
- medicine composition
- week
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
Landscapes
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
Abstract
The present invention relates to a kind of Eriocheir sinensis raising Chinese medicine composition and using method, the following component including constituting by ratio of weight and the number of copies: Radix Et Rhizoma Rhei: 10-15 part, Cortex Phellodendri: 8-10 part, the Radix Astragali: 15-20 part, Fructus Forsythiae: 10-15 part, Radix Scutellariae: 15-20 part, Cortex Moutan: 5-10 part, Radix Aconiti Lateralis Preparata: 8-10 part, Fructus Aurantii Immaturus: 10-15 part；The using method of this Chinese medicine composition is, Eriocheir sinensis raising Chinese medicine composition is made powder, is mixed into feedstuff in the ratio of 0.8-1.2%, make pellet and throw something and feed。The use of Chinese medicine composition of the present invention makes Eriocheir sinensis body weight and richness increase the most obvious, Eriocheir sinensis T-SOD vigor, CAT vigor, the raising of NO content and the minimizing of MDA content are played a driving role, and the healthy aquaculture of Eriocheir sinensis can be played the adjustment effect of long term beneficial by this Chinese medicine composition。
Description
Technical field
The invention belongs to technical field of aquaculture, particularly a kind of Eriocheir sinensis raising Chinese medicine composition and using method。
Background technology
Eriocheir sinensis (Chinesemittencrab), also known as crab, eriocheir sinensis, clear water Eriocheir sinensis, steamed crab or Eriocheir sinensis, formal name used at school Eriocheir sinensis, delicious meat, is the aquatic products of high nutritive value。Being distributed widely in lake, coastal various places, north and south within Chinese territory, wherein maximum with ChangJiang River yield, mouthfeel is the most delicious。In recent years, China's culture of Chinese mitten crab industry is flourish, becomes one of pillar industry of aquaculture industry。
But the fast development along with culture fishery, various environmental problems and the aquaculture disease of initiation that high-density breeding pattern is brought are continuously increased and urgently to be resolved hurrily, and the relevant issues of aquaculture hatchery aquatic products have become as the major obstacle of Eriocheir sinensis cultivation industry expansion。After cultivating year by year due to major part breeding water body, in water body, harmful levels of pathogens and parasite are on the increase, the continuous accumulation of traditional treatment medication, plurality of chemical drugs is caused to have very strong toxic and side effects, causing that crab drug disposition residual increases, not only cultured output declines, and jeopardizes health, so the application of natural Chinese medicinal herb, cause the attention of these those skilled in the art both at home and abroad。
Summary of the invention
It is an object of the invention to for the deficiencies in the prior art, and propose a kind of Eriocheir sinensis raising Chinese medicine composition and using method。
This invention address that it technical problem is that takes techniques below scheme to realize:
A kind of Eriocheir sinensis raising Chinese medicine composition, the following component including constituting by ratio of weight and the number of copies:
The using method of a kind of above-mentioned Eriocheir sinensis raising Chinese medicine composition, makes powder by Eriocheir sinensis raising Chinese medicine composition, is mixed into feedstuff in the ratio of 0.8-1.2%, make pellet and throw something and feed。
And, Chinese medicine composition is made powder, be mixed in feedstuff in the ratio of 1.0%, make pellet and carry out throwing something and feeding best results。
Advantages of the present invention and having the benefit effect that
1, when in breeding feed, the Eriocheir sinensis raising of the present invention is with Chinese medicine composition 1.0%, Eriocheir sinensis body weight is the most obvious with richness increase, when Eriocheir sinensis raising Chinese medicine composition addition is 1.0%, Eriocheir sinensis T-SOD vigor, CAT vigor, the raising of NO content and the minimizing of MDA content is played a driving role。
The Eriocheir sinensis raising Chinese medicine composition that 2, a certain plant utilizes the present invention carries out medium-sized test in continuous 13 years, the result obtained is identical with maiden trial, illustrates that the healthy aquaculture of Eriocheir sinensis can be played the adjustment effect of long term beneficial by this kind of drug regimen。
Detailed description of the invention
Hereinafter the invention process being further described, following example are illustrative, are not determinate, it is impossible to limit protection scope of the present invention with this。
A kind of Eriocheir sinensis raising Chinese medicine composition, the following component including constituting by ratio of weight and the number of copies:
The using method of above-mentioned Eriocheir sinensis raising Chinese medicine composition: Eriocheir sinensis raising Chinese medicine composition is made powder, is mixed into feedstuff in the ratio of 0.8-1.2%, makes pellet, throw something and feed。
Example 1
No. 1 formula Chinese medicine composition of composition by weight: Radix Et Rhizoma Rhei 15 parts, Cortex Phellodendri 10 parts, the Radix Astragali 20 parts, Fructus Forsythiae 15 parts, Radix Scutellariae 20 parts, Cortex Moutan 10 parts, Radix Aconiti Lateralis Preparata 10 parts, Fructus Aurantii Immaturus 15 parts。
In the normal feedstuff adding to have pulverized by 0.5% and 1.0% two Concentraton gradient by compound Chinese herb powder, the feedstuff after mixing that adds water is put into meat grinder and is made strip as test group feedstuff, the time of air-dry about one week, is twisted into the granular of 0.2cm size, subpackage label, is placed in shady and cool ventilation place standby；The normal feedstuff feedstuff as a control group being not added with Chinese medicine。
Compound Chinese herb is on the impact of superoxide dismutase SOD vigor in Eriocheir sinensis body
As shown in Table 1, after feedstuff adds No. 1 formula Chinese medicine composition, Eriocheir sinensis serum, muscle and visceral mass T-SOD vigor effect is as follows:
4th week Eriocheir sinensis serum T-SOD vigour, 1.0% Chinese medicine composition group with do not add Chinese medicine composition matched group, 0.5% Chinese medicine composition group has pole significant difference (P<0.01), does not add Chinese medicine composition matched group and 0.5% Chinese medicine composition group without significant difference (P>0.05)；
8th week, 1.0% Chinese medicine composition group with do not add Chinese medicine composition matched group, 0.5% Chinese medicine composition group has pole significant difference (P<0.01), does not add Chinese medicine composition matched group and 0.5% Chinese medicine composition group without significant difference (P>0.05)；
T-SOD in 4th week Eriocheir sinensis muscle compares, and extremely significantly (P<0.01), 0.5% group and 1.0% group without significant difference (P>0.05) for matched group and 0.5% group, 1.0% group difference。
All having pole significant difference (P < 0.01) between the T-SOD vigor three in the 8th week matched group, 0.5% group, 1.0% group Eriocheir sinensis muscle, matched group is substantially less than test group。
4th week Eriocheir sinensis visceral mass T-SOD vigour, 1.0% group and 0.5% group, all there were significant differences (P < 0.05) between matched group three；Matched group is significantly lower than test group；
8th week 0.5% group with 1.0% group, all there were significant differences (P<0.05) for matched group Eriocheir sinensis visceral mass T-SOD vigor, matched group and 1.0% group are without significant difference (P>0.05)。
During testing, in feedstuff, Eriocheir sinensis T-SOD vigor is generally and plays a driving role by interpolation compound recipe 1。
Table 1 compound Chinese herb is to Eriocheir sinensis serum, muscle and visceral mass T-SOD effect of vigor (meansigma methods ± standard error)
Chinese medicine composition is on the impact of cat catalase vigor in Eriocheir sinensis body
As seen in Table 2, after feedstuff adds No. 1 formula Chinese medicine composition, Eriocheir sinensis serum, muscle and visceral mass CAT effect of vigor is as follows:
4th week Eriocheir sinensis serum CAT vigour, 0.5% group and matched group all without significant difference (P>0.05), 1.0% group and matched group without significant difference (P>0.05) 0.5% group with 1.0% group there were significant differences (P<0.05)。
8th week Eriocheir sinensis serum CAT vigour, 0.5% group, 1.0% group, have pole significant difference (P < 0.01) between matched group three, the CAT vigor of matched group is between 1.0% group and 0.05% group。
CAT vigor in 4th week Eriocheir sinensis muscle, matched group and 1.0% group, 0.5% group are compared and are shown pole significant difference (P<0.01), 0.5% group with 1.0% group without significant difference (P>0.05)。
8th week Eriocheir sinensis muscle CAT vigor 0.5% group, 1.0% group, matched group are all without significant difference (P > 0.05)。
4th week Eriocheir sinensis visceral mass CAT vigour, 0.5% group, 1.0% group, matched group all significant differences (P < 0.05), matched group is higher than 1.0% group and 0.05% group。
8th week Eriocheir sinensis visceral mass CAT vigor, 0.5% group with matched group, 1.0% group have a pole significant difference (P<0.01), matched group and 1.0% group are without significant difference (P>0.05)。
Through compare feedstuff adds No. 1 formula Chinese medicine composition between 0.5%-1.0% to Eriocheir sinensis body in CAT vigor facilitation more apparent。
Table 2 compound Chinese herb is to Eriocheir sinensis serum, muscle and visceral mass CAT effect of vigor (meansigma methods ± standard error)
Chinese medicine composition is on the impact of malonaldehyde MDA content in Eriocheir sinensis body
Such as table 3 it can be seen that after feedstuff adds No. 1 formula Chinese medicine composition, Eriocheir sinensis serum, muscle and visceral mass MDA content are affected as follows:
MDA comparision contents in 4th week Eriocheir sinensis serum, 0.5% group with matched group, 1.0% group have a pole significant difference (P<0.01), matched group, 1.0% group without significant difference (P>0.05)。
MDA comparision contents in 8th week Eriocheir sinensis serum, 0.5% group is significantly higher than matched group, 1.0% group (P < 0.05)。
MDA comparision contents in 4th week Eriocheir sinensis muscle, 0.5% group is significantly higher than matched group and 1.0% group (P < 0.05)。
MDA comparision contents in 8th week Eriocheir sinensis muscle, matched group and 0.5% group, 1.0% group have pole significant difference (P<0.01), and 0.5% group, 1.0% group without significant difference (P>0.05)。
4th week Eriocheir sinensis visceral mass MDA comparision contents, 0.5% group and 1.0% group is below matched group and significant difference (P<0.05), and 0.5% group and 1.0% group without significant difference (P>0.05)。
8th week Eriocheir sinensis visceral mass MDA comparision contents, 1.0% group with 0.5% group, matched group have pole significant difference (P<0.01), 0.5% group, matched group is without significant difference (P>0.05)。
Effectively reducing MDA content in Eriocheir sinensis body through comparative descriptions compound Chinese herb, addition MDA content when 1.0% reduces the most obvious。
The impact (meansigma methods ± standard error) on Eriocheir sinensis serum, muscle and visceral mass MDA content of table 3 compound Chinese herb
Chinese medicine composition is on the impact of nitric oxide NO content in Eriocheir sinensis body
Such as table 4 it can be seen that after feedstuff adds No. 1 formula Chinese medicine composition, Eriocheir sinensis serum, muscle and visceral mass NO content are affected as follows:
4th week 0.5% group all there were significant differences (P<0.05) with the NO content in matched group, 1.0% group of Eriocheir sinensis serum, matched group and 1.0% group are without significant difference (P>0.05)。
8th week matched group, 0.5% group, between 1.0% three all without significant difference (P > 0.05)。
4th week Eriocheir sinensis muscle NO comparision contents, 1.0% group with matched group, 0.5% group all there were significant differences (P<0.05), matched group and 0.5% group are without significant difference (P>0.05)。
8th week matched group, 0.5% group, all there were significant differences (P < 0.05) between 1.0% three；0.5% group is below matched group with 1.0% group。
4th week Eriocheir sinensis visceral mass NO comparision contents, between matched group, 0.5% group, 1.0% group three, all there were significant differences (P < 0.05)；0.5% group and 1.0% group is below matched group。
Between 8th week Eriocheir sinensis visceral mass NO content matched group, 0.5% group, 1.0% group three, all there were significant differences (P < 0.05), and 0.5% group and 1.0% group is all higher than matched group。
Tests prove that the NO content of Eriocheir sinensis is played a driving role by No. 1 formula Chinese medicine composition generally。
The impact (meansigma methods ± standard error) on Eriocheir sinensis serum, muscle and visceral mass NO content of table 4 compound Chinese herb
Example 2
No. 2 formula Chinese medicine compositions of composition by weight: Radix Et Rhizoma Rhei 10 parts, Cortex Phellodendri 8 parts, the Radix Astragali 15 parts, Fructus Forsythiae 10 parts, Radix Scutellariae 10 parts, Cortex Moutan 5 parts, Radix Aconiti Lateralis Preparata 8 parts, Fructus Aurantii Immaturus 10 parts。
In the normal feedstuff adding to have pulverized by 1.0% and 1.2% two Concentraton gradient by compound Chinese herb powder, the feedstuff after mixing that adds water is put into meat grinder and is made strip as test group feedstuff, the time of air-dry about one week, is twisted into the granular of 0.2cm size, subpackage label, is placed in shady and cool ventilation place standby；The normal feedstuff feedstuff as a control group being not added with Chinese medicine。
1.0% group, 1.2% group and matched group are carried out test in 4 weeks and 8 weeks according to the mode of above-mentioned No. 1 formula Chinese medicine composition。
Compound Chinese herb is on the impact of superoxide dismutase SOD vigor in Eriocheir sinensis body
Such as table 5 it can be seen that feedstuff adds after No. 2 formula Chinese medicine compositions, Eriocheir sinensis serum, muscle and visceral mass T-SOD vigor effect is as follows:
4th week Eriocheir sinensis serum T-SOD vigour, 1.2% Chinese medicine composition group with do not add Chinese medicine composition matched group, 1.0% Chinese medicine composition group has pole significant difference (P<0.01), does not add Chinese medicine composition matched group and 1.0% Chinese medicine composition group without significant difference (P>0.05)；
8th week, between matched group, 1.0% group, 1.2% group Eriocheir sinensis serum T-SOD vigor three, all have pole significant difference (P < 0.01), 1.2% group apparently higher than other two groups, its T-SOD vigor reaches maximum 75.14U/mgprot。
T-SOD in 4th week Eriocheir sinensis muscle compares, and extremely significantly (P<0.01), 1.0% group and 1.2% group without significant difference (P>0.05) for matched group and 1.0% group, 1.2% group difference；It is 7.8U/mgprot that matched group T-SOD vigor reaches minima。
All having pole significant difference (P < 0.01) between the T-SOD vigor three in the 8th week matched group, 1.0% group, 1.2% group Eriocheir sinensis muscle, matched group is significantly lower than test group, and its T-SOD vigor reaches minima 15.25U/mgpro。
4th week Eriocheir sinensis visceral mass T-SOD vigour, 1.2% group and 1.0% group, matched group variant notable (P < 0.05)；Matched group is significantly lower than test group；
8th week 1.0% group with 1.2% group, matched group Eriocheir sinensis visceral mass T-SOD vigor difference notable (P > 0.05)。
During testing, in feedstuff, Eriocheir sinensis T-SOD vigor is generally and plays a driving role by interpolation compound recipe 2。
Table 5 compound Chinese herb is to Eriocheir sinensis serum, muscle and visceral mass T-SOD effect of vigor (meansigma methods ± standard error)
Chinese medicine composition is on the impact of cat catalase vigor in Eriocheir sinensis body
Such as table 6 it can be seen that feedstuff adds after No. 2 formula Chinese medicine compositions, Eriocheir sinensis serum, muscle and visceral mass CAT effect of vigor is as follows:
4th week Eriocheir sinensis serum CAT vigour, 1.0% group and matched group all without significant difference (P>0.05), 1.2% group with 0.5% group, there were significant differences for matched group (P<0.05)。
8th week Eriocheir sinensis serum CAT vigour, 1.0% group, 1.2% group, all there were significant differences (P < 0.05) between matched group three。
CAT vigor in 4th week Eriocheir sinensis muscle, matched group and 1.2% group, 1.0% group are compared and are shown significant difference (P<0.05), 1.0% group with 1.2% group without significant difference (P>0.05)。
8th week Eriocheir sinensis muscle CAT vigor 1.0% group, 1.2% group, matched group are all without significant difference (P > 0.05)。
4th week Eriocheir sinensis visceral mass CAT vigour, 1.0% group, 1.2% group, matched group all significant differences (P < 0.05), matched group is lower than 1.2% group and 1.0% group。
8th week Eriocheir sinensis visceral mass CAT vigor, 1.2% group with matched group, 1.0% group all there were significant differences (P<0.05), matched group and 1.0% group are without significant difference (P>0.05)。
Through compare feedstuff adds No. 2 formula Chinese medicine compositions between 1.0%-1.2% to Eriocheir sinensis body in CAT vigor facilitation more apparent。
Table 6 compound Chinese herb is to Eriocheir sinensis serum, muscle and visceral mass CAT effect of vigor (meansigma methods ± standard error)
Chinese medicine composition is on the impact of malonaldehyde MDA content in Eriocheir sinensis body
Such as table 7 it can be seen that after feedstuff adds No. 2 formula Chinese medicine compositions, Eriocheir sinensis serum, muscle and visceral mass MDA content are affected as follows:
MDA comparision contents in 4th week Eriocheir sinensis serum, 1.2% group, matched group, 1.0% group without significant difference (P > 0.05)。
MDA comparision contents in 8th week Eriocheir sinensis serum, 1.2% group is significantly smaller than matched group, 1.0% group (P < 0.05)。Matched group, 1.0% group of difference not notable (P > 0.05)。
MDA comparision contents in 4th week Eriocheir sinensis muscle, matched group, 1.0% group, 1.2% group difference not notable (P > 0.05)。
MDA comparision contents in 8th week Eriocheir sinensis muscle, matched group is significantly higher than 1.0% group, 1.2% group (P<0.01), and 1.0% group, 1.2% group without significant difference (P>0.05)。
4th week Eriocheir sinensis visceral mass MDA comparision contents, 0.5% group and 1.0% group is below matched group and significant difference (P<0.05), and 0.5% group and 1.0% group without significant difference (P>0.05)。
8th week Eriocheir sinensis visceral mass MDA comparision contents, 1.0% group with 0.5% group, all there were significant differences for matched group (P<0.05), 0.5% group, matched group is without significant difference (P>0.05)。
Effectively reducing MDA content in Eriocheir sinensis body through comparative descriptions compound Chinese herb, addition MDA content when 1.0% reduces the most obvious。
The impact (meansigma methods ± standard error) on Eriocheir sinensis serum, muscle and visceral mass MDA content of table 7 compound Chinese herb
Chinese medicine composition is on the impact of nitric oxide NO content in Eriocheir sinensis body
Such as table 8 it can be seen that after feedstuff adds No. 2 formula Chinese medicine compositions, Eriocheir sinensis serum, muscle and visceral mass NO content are affected as follows:
4th week 1.0% group be substantially less than matched group, 1.2% group (P<0.05), matched group and 1.2% group are without significant difference (P>0.05)。
8th week 1.0% group, 1.2% group be significantly higher than matched group (P < 0.05)；1.0% group, 1.2% group without significant difference (P > 0.05)。
4th week Eriocheir sinensis muscle NO comparision contents, 1.2% group with matched group, 1.0% group all there were significant differences (P<0.05), matched group and 1.0% group are without significant difference (P>0.05)。
8th week matched group, 1.0% group, between 1.2% three all with or without significant difference (P > 0.05)。
4th week Eriocheir sinensis visceral mass NO comparision contents, matched group, 1.0% group, between 1.2% three all with or without significant difference (P > 0.05)。
Within 8th week, Eriocheir sinensis visceral mass NO content matched group is substantially less than 1.0% group, 1.2% group (P<0.05), 1.0% group, 1.2% group difference not notable (P>0.05)。
Tests prove that the NO content of Eriocheir sinensis is played a driving role by No. 1 formula Chinese medicine composition generally。
The impact (meansigma methods ± standard error) on Eriocheir sinensis serum, muscle and visceral mass NO content of table 8 compound Chinese herb
Test result indicate that,
The following component that Eriocheir sinensis raising Chinese medicine composition is constituted by ratio of weight and the number of copies is maximally efficient:
The using dosage of above-mentioned Eriocheir sinensis raising Chinese medicine composition is mixed into feedstuff in the ratio of 0.8-1.2%, makes pellet, carries out the best results thrown something and fed。
Claims (3)
1. an Eriocheir sinensis raising Chinese medicine composition, it is characterised in that the component that this Chinese medicine composition is constituted by ratio of weight and the number of copies is as follows:
2. the using method of an Eriocheir sinensis raising Chinese medicine composition according to claim 1, it is characterised in that: Eriocheir sinensis raising Chinese medicine composition is made powder, is mixed into feedstuff in the ratio of 0.8-1.2%, make pellet and throw something and feed。
3. the using method of Eriocheir sinensis raising Chinese medicine composition according to claim 2, it is characterised in that: Chinese medicine composition is made powder, is mixed in feedstuff in the ratio of 1.0%, make pellet and carry out throwing something and feeding best results。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410454963.9A CN104256065B (en) | 2014-09-09 | 2014-09-09 | Eriocheir sinensis raising Chinese medicine composition and using method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410454963.9A CN104256065B (en) | 2014-09-09 | 2014-09-09 | Eriocheir sinensis raising Chinese medicine composition and using method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104256065A CN104256065A (en) | 2015-01-07 |
| CN104256065B true CN104256065B (en) | 2016-06-22 |
Family
ID=52147751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410454963.9A Expired - Fee Related CN104256065B (en) | 2014-09-09 | 2014-09-09 | Eriocheir sinensis raising Chinese medicine composition and using method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104256065B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108029605A (en) * | 2017-12-26 | 2018-05-15 | 广西金海环岛渔业有限公司 | Improve the cultural method of mud crab weight |
| CN108850705A (en) * | 2018-07-03 | 2018-11-23 | 中国水产科学研究院淡水渔业研究中心 | Nutrient enrichment fodder and preparation method thereof after a kind of Eriocheir sinensis shell |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101124945A (en) * | 2007-09-27 | 2008-02-20 | 天津农学院 | Special-purpose traditional Chinese medicinal composition for fresh water fish infectious diseases |
| CN101406248A (en) * | 2008-11-17 | 2009-04-15 | 浙江大学 | Nonspecific immunity strengthening agent for shrimps and crabs, and preparation method thereof |
-
2014
- 2014-09-09 CN CN201410454963.9A patent/CN104256065B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101124945A (en) * | 2007-09-27 | 2008-02-20 | 天津农学院 | Special-purpose traditional Chinese medicinal composition for fresh water fish infectious diseases |
| CN101406248A (en) * | 2008-11-17 | 2009-04-15 | 浙江大学 | Nonspecific immunity strengthening agent for shrimps and crabs, and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 中草药对高水温胁迫下中华绒螯蟹非特异性免疫因子的影响;马盛群;《淡水渔业》;20131130;第43卷(第6期);第62-66页 * |
| 复方中草药对中华绒螯蟹免疫因子的影响;刘丽平;《南京师大学报（自然科学版）》;20080331;第31卷(第1期);第109-113页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104256065A (en) | 2015-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104012807B (en) | A kind of livestock and poultry antiviral B B-complex premixed feed preparation and preparation method and application thereof | |
| CN103859208B (en) | Piglet health protection fodder and preparation method thereof | |
| CN102429129A (en) | Chinese herbal medicine feed additive for improving disease resistance of wild Queshan chicken | |
| CN102920990A (en) | Chinese herbal medicinal prescription for preventing and treating aeromonas hydrophila fish disease | |
| CN101966247A (en) | Method for treating grass carp bacterial 'rotten gill disease, enteritis and red skin disease' by using pure Chinese herbal medicament preparation | |
| CN104522320A (en) | Natural plant anticoccidial feed additive and application thereof | |
| CN102028121B (en) | Additive premix feed for pigs and preparation method thereof | |
| CN104206710B (en) | Traditional Chinese medicinal feed additive containing N-carbamylglutamic acid, and its application | |
| CN107518194A (en) | It is a kind of to prevent slow-growing Chinese herbal feed additive of piglet and preparation method thereof | |
| CN109221735A (en) | A kind of pannage containing Chinese medicine | |
| CN105395665A (en) | Chinese herbal medicine composition capable of preventing and treating fish and shrimp white stool | |
| CN103202409A (en) | Special feed additive for grass carp | |
| CN103598422B (en) | Chinese herbal medicine feed addictive for river crabs | |
| CN102657764A (en) | Chinese medicinal powder for preventing and treating chicken coccidiosis and preparation method thereof | |
| CN104256065B (en) | Eriocheir sinensis raising Chinese medicine composition and using method | |
| CN104587326A (en) | Composite traditional Chinese medicine insecticidal bactericidal agent for grass carp breeding and preparation method thereof | |
| CN103202410A (en) | Feed additive for improving disease resistance of grass carps and improving meat quality and flavor | |
| CN103749996B (en) | Method used for preparing meat chicken feed via fermentation | |
| CN102579681B (en) | Pure Chinese medicinal composition for improving egg yolk color and preparation method thereof | |
| CN102488755B (en) | Fishing Chinese herbal composition capable of inhibiting germs and preparation method thereof | |
| CN101401617A (en) | Spirulina feedstuff additive for livestock, poultry biology and aquatic livestock, and method of preparing the same | |
| CN107279524A (en) | A kind of fattening pannage Chinese medicine additive | |
| CN103110779A (en) | Composition containing Chinese yam and application thereof | |
| CN106107114A (en) | A kind of pig's feed additive and preparation method thereof | |
| CN104799010A (en) | Feed additive for improving physique of monkey and preparation method of feed additive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170502 Address after: 300480 No. 22, Jing Jing Road, Xiqing District, Tianjin Patentee after: Tianjin Yi Ming aquatic breeding Co., Ltd. Address before: 300384 Xiqing District, Tianjin Jing Jing Road, No. 22 Patentee before: Tianjin Agricultural College |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160622 Termination date: 20180909 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |